Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;77(3):435-437.
doi: 10.1007/s00228-020-03008-6. Epub 2020 Oct 4.

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19

Chia Siang Kow  1 , Mamoon Aldeyab  2 , Syed Shahzad Hasan  2   3
Affiliations

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19

Chia Siang Kow et al. Eur J Clin Pharmacol. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. Heck J, Stichtenoth DO, Mettin R, Jöckel J, Bickel C, Krichevsky B (2020) Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature [published online ahead of print, 2020 Aug 6]. Eur J Clin Pharmacol 1-4 - PMC - PubMed
    1. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial [published correction appears in Lancet. 2020 May 30;395(10238):1694] Lancet. 2020;395(10236):1569–1578. doi: 10.1016/S0140-6736(20)31022-9. - DOI - PMC - PubMed
    1. Beigel JH, Tomashek KM, Dodd LE, et al (2020) Remdesivir for the treatment of Covid-19 - preliminary report [published online ahead of print, 2020 May 22]. N Engl J Med. NEJMoa2007764 - PubMed
    1. Goldman JD, Lye DCB, Hui DS et al (2020) Remdesivir for 5 or 10 days in patients with severe Covid-19 [published online ahead of print, 2020 May 27]. N Engl J Med. 10.1056/NEJMoa2015301 - PMC - PubMed
    1. Spinner CD, Gottlieb RL, Criner GJ, et al. (2020) Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: A Randomized Clinical Trial. JAMA. 324(11):1048–1057 - PMC - PubMed

MeSH terms